Theriva Biologics Inc (TOVX)
AMEX
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -102.188 | -107.103 | -103.273 | -67.866 | -97.929 | -58.874 | -28.159 | -28.878 |
Return on Equity (%) | -315.963 | 3813.264 | -470.574 | -245.398 | 292.125 | -80.144 | -34.161 | -41.33 |
Return on Invested Capital (%) | -456.021 | 4349.793 | -152.798 | -82.663 | -121.684 | -40.425 | -30.889 | -45.385 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.015 | -0.022 | 0.459 | 0.145 | 0.047 | 0.405 | 0.669 | 0.303 |
Earnings Per Share | -0.186 | -0.14 | -0.561 | -0.347 | -0.213 | -0.143 | -0.448 | -0.391 |
Cash Per Share | 0.13 | 0.108 | 0.642 | 0.324 | 0.106 | 0.417 | 0.935 | 0.493 |
Working Capital Per Share | 0.012 | 0.052 | 0.58 | 0.24 | 0.084 | 0.404 | 0.861 | 0.44 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.189 | -0.098 | -0.298 | -0.332 | -0.172 | -0.088 | -0.472 | -0.425 |
EBITDA Per Share | -0.189 | -0.098 | -0.298 | -0.332 | -0.172 | -0.088 | -0.472 | -0.425 |
Free Cash Flow Per Share | -0.183 | -0.14 | -0.567 | -0.352 | -0.217 | -0.144 | -0.447 | -0.389 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 117.17M | 128.57M | 15.48M | 16.81M | 29.25M | 132.04M | 15.12M | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 15.12M | N/A | 17.04M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 4.09M |
Price to Earnings Ratio | -0.22 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.18 |
Price to Book Ratio | 0.1 |
Dividend Yield | - |
Shares Outstanding | 2.78M |
Average Volume (1 week) | 4.53M |
Average Volume (1 Month) | 1.04M |
52 Week Change | -86.51% |
52 Week High | 17.1125 |
52 Week Low | 1.14 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.